Ben Youssef Yosra, Gmidène Abir, Bouabid Zahreddine, Bouallegui Sonia, Sriha Badreddine, Zaier Monia, Sennana Hlima, Khelif Abserrahim
Department of clinical hematology Farhat Hached, University Hospital, Sousse, Tunisia.
Ann Biol Clin (Paris). 2013 Jul-Aug;71(4):457-60. doi: 10.1684/abc.2013.0856.
The association of essential thrombocythemia and multiple myeloma is extremely rare, with only three patients previously treated with hydroxyurea reported in the literature until now. In this paper, we report the case of a 66 year old male who developed IgG-kappa M six years after the diagnosis of essential thrombocythemia, for which he had received hydroyurea. The possible etiological and pathogenic link between both these entities is here discussed.
